Skip to main content
. 2020 Dec 1;10:20918. doi: 10.1038/s41598-020-77788-3

Table 1.

Biodistribution of 18F-mFBG 4 h after injection of mice bearing Kelly xenografts, pre-treated with AZD2014 (25 mg/kg/day) or vehicle control (DMSO 10%, PEG400 90%) for 3 days.

Kelly 18F-mFBG biodistribution 4 h p.i. (mean %ID/g ± SD)
Vehicle AZD2014 (25 mg/kg/day)
N =  3 3
Blood 0.22 ± 0.05 0.19 ± 0.03
Heart 6.34 ± 1.41 4.22 ± 0.85
Lungs 1.52 ± 0.22 1.31 ± 0.39
Kidney 1.11 ± 0.47 0.97 ± 0.17
Spleen 3.77 ± 0.82 4.58 ± 0.77
Liver 2.37 ± 0.71 2.08 ± 0.45
Pancreas 1.26 ± 0.28 1.25 ± 0.21
Tumour 0.39 ± 0.13 0.74 ± 0.25
Bone 1.43 ± 0.83 0.99 ± 0.07
Small intestine 6.57 ± 1.12 7.30 ± 1.11
Muscle 0.74 ± 0.23 0.64 ± 0.17
Brown adipose 5.84 ± 2.44 7.20 ± 0.88
Tumour:blood 1.75 ± 0.29 4.16 ± 1.89
Tumour:muscle 0.53 ± 0.01 1.23 ± 0.61

Data are presented as mean ± SD, n = 3 per group.